These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4802769)

  • 21. [Effects of sodium and calcium on the conversion of fibrinogen to fibrin].
    Marguerie G; Hudry G; Hollard D
    Thromb Diath Haemorrh; 1970 Dec; 24(3):373-84. PubMed ID: 5503938
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification of critical residues on thrombin mediating its interaction with fibrin.
    Hall SW; Gibbs CS; Leung LL
    Thromb Haemost; 2001 Dec; 86(6):1466-74. PubMed ID: 11776315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A comparative study of lanthanum, cerium and fluoride on the prevention of root surface caries by various procedure].
    Jin H; Zhang W; Liu A
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1997 May; 32(3):143-5. PubMed ID: 10680522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Action of water-insoluble trypsin derivatives on fibrinogen clottability.
    Alexander B; Rimon A; Katchalski E
    Thromb Diath Haemorrh; 1966 Dec; 16(3):507-25. PubMed ID: 5996672
    [No Abstract]   [Full Text] [Related]  

  • 25. The inactivation of hemostatic factors by hematin.
    Green D; Reynolds N; Klein J; Kohl H; Ts'ao CH
    J Lab Clin Med; 1983 Sep; 102(3):361-9. PubMed ID: 6411843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duvernoy's gland secretion of Philodryas patagoniensis from the northeast of Argentina: its effects on blood coagulation.
    Peichoto ME; Leiva LC; Guaimás Moya LE; Rey L; Acosta O
    Toxicon; 2005 Mar; 45(4):527-34. PubMed ID: 15733575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chelate formation of riboflavine with Yttrium (III), Lanthanum (III), and Cerium (III).
    Sekhon BS; Chopra SL
    Z Naturforsch C Biosci; 1974; 29(7-8):339-42. PubMed ID: 4278027
    [No Abstract]   [Full Text] [Related]  

  • 28. Conversion of fibrinogen to fibrin. The correlation between clotting kinetics and morphology of fibrin polymerized in different solvent media.
    Conio G; Trefiletti V; Troglia C; Patrone E
    Biopolymers; 1976 Oct; 15(10):1979-90. PubMed ID: 963239
    [No Abstract]   [Full Text] [Related]  

  • 29. On the reaction of purified bovine thrombin with N-acetylimidazole.
    Lundblad RL; Harrison JH; Mann KG
    Biochemistry; 1973 Jan; 12(3):409-13. PubMed ID: 4734230
    [No Abstract]   [Full Text] [Related]  

  • 30. Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway.
    Lovely RS; Boshkov LK; Marzec UM; Hanson SR; Farrell DH
    Br J Haematol; 2007 Nov; 139(3):494-503. PubMed ID: 17910639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions of bovine fibrinogen and thrombin. Early events in the development of clot structure.
    Landis WJ; Waugh DF
    Arch Biochem Biophys; 1975 Jun; 168(2):498-511. PubMed ID: 1169913
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of macromolecules as carriers of cytotoxic groups. 3. Synthesis and characterisation of polypeptidyl-fibrinogen derivatives.
    Szekerke M; Wade R; Whisson ME
    Neoplasma; 1973; 20(2):163-9. PubMed ID: 4707837
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I).
    de Bosch NB; Mosesson MW; Ruiz-Sáez A; Echenagucia M; Rodriguez-Lemoin A
    Thromb Haemost; 2002 Aug; 88(2):253-8. PubMed ID: 12195697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the interaction of recombinant apolipoprotein(a) with modified fibrinogen surfaces and fibrin clots.
    Sangrar W; Koschinsky ML
    Biochem Cell Biol; 2000; 78(4):519-25. PubMed ID: 11012092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of some antineoplastic drugs on inhibiting thrombin catalizing fibrinogen clotting in vitro.
    Lu D; Cao J; Huang Y; Gong L; Chen X; Chen E; Xu B
    Chin Med J (Engl); 1999 Nov; 112(11):1052-3. PubMed ID: 11721472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optical rotatory dispersion of the thrombin-induced conversion of fibrinogen to fibrin monomer.
    KAY CM; MARSH MM
    Nature; 1961 Jan; 189():307-8. PubMed ID: 13752010
    [No Abstract]   [Full Text] [Related]  

  • 37. Oligonucleotide inhibitors of human thrombin that bind distinct epitopes.
    Tasset DM; Kubik MF; Steiner W
    J Mol Biol; 1997 Oct; 272(5):688-98. PubMed ID: 9368651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Investigation of the physicochemical properties of fibrinogen and fibrin-monomer of bull].
    Lugovskoï EV
    Ukr Biokhim Zh; 1967; 39(2):130-6. PubMed ID: 5603056
    [No Abstract]   [Full Text] [Related]  

  • 39. On the structure of functional sites in fibrinogen.
    Henschen A
    Thromb Res; 1983; Suppl 5():27-39. PubMed ID: 6225216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Citrullinated fibrinogen inhibits thrombin-catalysed fibrin polymerization.
    Nakayama-Hamada M; Suzuki A; Furukawa H; Yamada R; Yamamoto K
    J Biochem; 2008 Sep; 144(3):393-8. PubMed ID: 18583356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.